title: Thyroid function and plasma selenium in chronic uremic patients on hemodialysis treatment.
abstract: It has been shown recently that Selenium (Se), an essential trace element for humans, is involved in the regulation of thyroid function, since the enzyme that catalyzes the liver conversion of the thyroid hormone T4 to the more active form T3 is a selenoenzyme. In chronic uremic patients, low blood Se levels as well as thyroid function abnormalities are often found. The present study was carried out to verify whether any correlation exists between Se levels and thyroid function, and to evaluate possible changes in hormonal pattern during Se supplementation in 10 chronic uremic patients on hemodialysis (HD) treatment. Se was supplemented orally as sodium selenite over six consecutive months. Basic plasma Se levels were significantly lower in patients than in normal controls. Right from the start of Se supplementation, plasma Se concentration promptly normalized and leveled off in the normal range throughout the study. Significant increase of FT3 and reduction of TSH levels were detected during Se supplementation. In Se-supplemented patients, a significant direct correlation was also found between reverse T3 (rT3) and TSH, and a significant inverse correlation was found between Se and TSH. Our results suggest that Se deficiency in chronic uremic patients represents a factor influencing the thyroid function and that the Se status should be determined in the evaluation of thyroid metabolism in these patients.
authors.affiliation: Chair of Endocrinology, University G. D'Annunzio, Chieti, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Napolitano
authors.forename: M
authors.initials: M
authors.lastname: Bonomini
authors.forename: G
authors.initials: G
authors.lastname: Bomba
authors.forename: I
authors.initials: I
authors.lastname: Bucci
authors.forename: V
authors.initials: V
authors.lastname: Todisco
authors.forename: A
authors.initials: A
authors.lastname: Albertazzi
authors.forename: F
authors.initials: F
authors.lastname: Monaco
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D005260:Female; D006801:Humans; D015592:Immunoradiometric Assay; D008297:Male; D008875:Middle Aged; D011863:Radioimmunoassay; D006435:Renal Dialysis; D012643:Selenium / Q000097:blood*; D018038:Sodium Selenite / Q000008:administration & dosage / Q000494:pharmacology; D013054:Spectrophotometry, Atomic; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000502:physiology*; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood; D014511:Uremia / Q000097:blood* / Q000503:physiopathology / Q000628:therapy
chemical_list: D014284:Triiodothyronine; D013972:Thyrotropin; D012643:Selenium; D018038:Sodium Selenite; D013974:Thyroxine